Canadian medical cannabis company Canopy Growth has paid €225.9m in cash for C3, a German producer of pharmaceutical grade cannabinoids
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.